Role of pneumococcal pneumolysin in the induction of an inflammatory response in human epithelial cells
In-Hwa Yoo
Department of Biotechnology and Bioinformatics, Korea University, Chungnam, Korea
Search for more papers by this authorHee-Sung Shin
Department of Biotechnology and Bioinformatics, Korea University, Chungnam, Korea
Search for more papers by this authorYong-Jae Kim
Department of Biotechnology and Bioinformatics, Korea University, Chungnam, Korea
Search for more papers by this authorHyong-Bai Kim
Department of Biotechnology and Bioinformatics, Korea University, Chungnam, Korea
Search for more papers by this authorShouguang Jin
Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA
Search for more papers by this authorUn-Hwan Ha
Department of Biotechnology and Bioinformatics, Korea University, Chungnam, Korea
Search for more papers by this authorIn-Hwa Yoo
Department of Biotechnology and Bioinformatics, Korea University, Chungnam, Korea
Search for more papers by this authorHee-Sung Shin
Department of Biotechnology and Bioinformatics, Korea University, Chungnam, Korea
Search for more papers by this authorYong-Jae Kim
Department of Biotechnology and Bioinformatics, Korea University, Chungnam, Korea
Search for more papers by this authorHyong-Bai Kim
Department of Biotechnology and Bioinformatics, Korea University, Chungnam, Korea
Search for more papers by this authorShouguang Jin
Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA
Search for more papers by this authorUn-Hwan Ha
Department of Biotechnology and Bioinformatics, Korea University, Chungnam, Korea
Search for more papers by this authorEditor: Nicholas Carbonetti
Abstract
Epithelial cells act as the first line of host defense against microorganisms by producing a range of molecules for clearance. Proinflammatory cytokines facilitate the clearance of invaders by the recruitment and activation of leukocytes. Upregulation of cytokine expression thus represents an important host innate defense response against invading microorganisms such as Streptococcus pneumoniae. Histological analysis of the airway revealed less leukocyte infiltration during the early stage of pneumococcal infection, when compared with nontypable Haemophilus influenzae (NTHi) infection. Here, we report that S. pneumoniae is less potent in inducing proinflammatory cytokine expression compared with NTHi. Among numerous virulence factors, pneumococcal pneumolysin was found to be the major factor responsible for the induction of inflammation. Interestingly, pneumolysin induces cytokine expression to a lesser extent at the early stage of infection, but becomes more potent in inducing inflammation at the late stage. Thus, this study reveals that pneumolysin induces the proinflammatory cytokine expression in a time-dependent manner.
References
- Avery OT, MacLeod CM & McCarty M (1979) Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Inductions of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med 149: 297–326.
- Baldassare JJ, Bi Y & Bellone CJ (1999) The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J Immunol 162: 5367–5373.
- Berry AM, Yother J, Briles DE, Hansman D & Paton JC (1989) Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect Immun 57: 2037–2042.
- Black S, Shinefield H, Fireman B et al. (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19: 187–195.
- Bluestone CD, Stephenson JS & Martin LM (1992) Ten-year review of otitis media pathogens. Pediatr Infect Dis J 11: S7–11.
- Braun JS, Novak R, Gao G, Murray PJ & Shenep JL (1999) Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect Immun 67: 3750–3756.
- Briles DE, Crain MJ, Gray BM, Forman C & Yother J (1992) Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 60: 111–116.
- Bruyn GA & Van Furth R (1991) Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations. Eur J Clin Microbiol Infec Dis 10: 897–910.
- Canvin JR, Marvin AP, Sivakumaran M, Paton JC, Boulnois GJ, Andrew PW & Mitchell TJ (1995) The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J Infect Dis 172: 119–123.
- Chun KS & Surh YJ (2004) Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem Pharmacol 68: 1089–1100.
- Clemans DL, Bauer RJ, Hanson JA, Hobbs MV, St Geme JW III, Marrs CF & Gilsdorf JR (2000) Induction of proinflammatory cytokines from human respiratory epithelial cells after stimulation by nontypeable Haemophilus influenzae. Infect Immun 68: 4430–4440.
- Cockeran R, Steel HC, Mitchell TJ, Feldman C & Anderson R (2001) Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils. Infect Immun 69: 3494–3496.
- Cockeran R, Durandt C, Feldman C, Mitchell TJ & Anderson R (2002) Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J Infect Dis 186: 562–565.
- Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I & Tuomanen EI (1995) Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377: 435–438.
- Dave S, Brooks-Walter A, Pangburn MK & McDaniel LS (2001) PspC, a pneumococcal surface protein, binds human factor H. Infect Immun 69: 3435–3437.
- Dinarello CA (2000) Proinflammatory cytokines. Chest 118: 503–508.
- Faden H, Stanievich J, Brodsky L, Bernstein J & Ogra PL (1990) Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J 9: 623–626.
- Ferrante A, Rowan-Kelly B & Paton JC (1984) Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin. Infect Immun 46: 585–589.
- Givon-Lavi N, Fraser D, Porat N & Dagan R (2002) Spread of Streptococcus pneumoniae and antibiotic-resistant S. pneumoniae from day-care center attendees to their younger siblings. J Infect Dis 186: 1608–1614.
- Gok U, Bulut Y, Keles E, Yalcin S & Doymaz MZ (2001) Bacteriological and PCR analysis of clinical material aspirated from otitis media with effusions. Int J Pediatr Otorhi 60: 49–54.
- Ha U, Lim JH, Jono H et al. (2007) A novel role for IkappaB kinase (IKK) alpha and IKKbeta in ERK-dependent up-regulation of MUC5AC mucin transcription by Streptococcus pneumoniae. J Immunol 178: 1736–1747.
- Ha UH, Lim JH, Kim HJ, Wu W, Jin S, Xu H & Li JD (2008) MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway. J Biol Chem 283: 30624–30631.
- Hausdorff WP, Bryant J, Kloek C, Paradiso PR & Siber GR (2000a) The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 30: 122–140.
- Hausdorff WP, Bryant J, Paradiso PR & Siber GR (2000b) Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30: 100–121.
- Henderson B, Poole S & Wilson M (1996) Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 60: 316–341.
- Hersh D, Weiss J & Zychlinsky A (1998) How bacteria initiate inflammation: aspects of the emerging story. Curr Opin Microbiol 1: 43–48.
- Houldsworth S, Andrew PW & Mitchell TJ (1994) Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect Immun 62: 1501–1503.
- Jedrzejas MJ (2001) Pneumococcal virulence factors: structure and function. Microbiol Mol Biol R 65: 187–207.
- Jono H, Shuto T, Xu H et al. (2002) Transforming growth factor-beta-Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription. J Biol Chem 277: 45547–45557.
- Kalin M (1998) Pneumococcal serotypes and their clinical relevance. Thorax 53: 159–162.
- Kweon SM, Wang B, Rixter D et al. (2006) Synergistic activation of NF-kappaB by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKKbeta-IkappaBalpha, and p38 MAPK. Biochem Bioph Res Co 351: 368–375.
- Lagoa CE, Vodovotz Y, Stolz DB et al. (2005) The role of hepatic type 1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shock. Hepatology 42: 390–399.
- Lim JH, Jono H, Koga T et al. (2007a) Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice. PLoS One 2: e1032.
- Lim JH, Stirling B, Derry J et al. (2007b) Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity 27: 349–360.
- Madsen M, Lebenthal Y, Cheng Q, Smith BL & Hostetter MK (2000) A pneumococcal protein that elicits interleukin-8 from pulmonary epithelial cells. J Infect Dis 181: 1330–1336.
- Mitchell TJ (2006) Streptococcus pneumoniae: infection, inflammation and disease. Adv Exp Med Biol 582: 111–124.
- Mitchell TJ & Andrew PW (1997) Biological properties of pneumolysin. Microb Drug Resist 3: 19–26.
- Murphy TF (2006) The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis 19: 225–230.
- Obaro SK (2002) The new pneumococcal vaccine. Clin Microbiol Infec 8: 623–633.
- Ozyilmaz E, Akan OA, Gulhan M, Ahmed K & Nagatake T (2005) Major bacteria of community-acquired respiratory tract infections in Turkey. Jpn J Infect Dis 58: 50–52.
- Paton JC & Ferrante A (1983) Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect Immun 41: 1212–1216.
- Paton JC, Rowan-Kelly B & Ferrante A (1984) Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun 43: 1085–1087.
- Paton JC, Berry AM & Lock RA (1997) Molecular analysis of putative pneumococcal virulence proteins. Microb Drug Resist 3: 1–10.
- Price KE & Camilli A (2009) Pneumolysin localizes to the cell wall of Streptococcus pneumoniae. J Bacteriol 191: 2163–2168.
- Rijneveld AW, Van Den Dobbelsteen GP, Florquin S, Standiford TJ, Speelman P, Van Alphen L & Van Der Poll T (2002) Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J Infect Dis 185: 123–126.
- Rosenow C, Ryan P, Weiser JN, Johnson S, Fontan P, Ortqvist A & Masure HR (1997) Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol 25: 819–829.
- Shuto T, Xu H, Wang B et al. (2001) Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. P Natl Acad Sci USA 98: 8774–8779.
- Spratt BG & Greenwood BM (2000) Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet 356: 1210–1211.
- Srivastava A, Henneke P, Visintin A et al. (2005) The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect Immun 73: 6479–6487.
- Tuomanen E, Liu H, Hengstler B, Zak O & Tomasz A (1985) The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 151: 859–868.
- Ware LB, Bastarache JA & Wang L (2005) Coagulation and fibrinolysis in human acute lung injury – new therapeutic targets? Keio J Med 54: 142–149.
- Wheeler J, Freeman R, Steward M et al. (1999) Detection of pneumolysin in sputum. J Med Microbiol 48: 863–866.
- Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R & Golenbock D (1999) Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163: 1–5.